Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 12/20 | 0.39 |
| ▸ | ADORA1 | P30542 | 5/20 | 0.37 |
| ▸ | ADORA2A | P29274 | 5/20 | 0.37 |
| ▸ | ADORA2B | P29275 | 4/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | ALB | P02768 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22757464 | 0.89 | ADORA3 (0.41) | ADORA3ADORA1ADORA2A | |
| SCHEMBL22757369 | 0.73 | ADORA3 (0.47) | ADORA3ADORA1ADORA2AADORA2BLMNA | |
| SCHEMBL22757500 | 0.72 | ADORA3 (0.55) | ADORA3ADORA1ADORA2AADORA2B | |
| SCHEMBL22757418 | 0.70 | ADORA3 (0.39) | ADORA3ADORA1ADORA2AADORA2B | |
| SCHEMBL22757470 | 0.70 | ADORA1 (0.41) | ADORA3ADORA1ADORA2AADORA2B | |
| SCHEMBL22757330 | 0.69 | ADORA3 (0.46) | ADORA3ADORA1ADORA2AADORA2B | |
| SCHEMBL24600792 | 0.67 | LMNA (0.47) | ADORA3ALDH1A1LMNACYP1A2 | |
| SCHEMBL22757370 | 0.65 | PI4KA (0.44) | ADORA3ADORA1ADORA2AADORA2BALDH1A1 | |
| SCHEMBL12826793 | 0.65 | PDE4D (0.55) | ADORA3ADORA1ADORA2ALMNA | |
| SCHEMBL23898646 | 0.64 | ADORA2A (0.54) | ADORA3ADORA1ADORA2AADORA2BALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020247546-A1 | ADENOSINE ANALOGS FOR THE TREATMENT OF DISEASE | BIOINTERVENE, INC. (US) | 2020-12-10 | — | — | WO | disclosed |